Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5595 record(s)

Req # A-2021-001155

Adverse Drug Reactions (ADRs) for CABAZITAXEL. Report numbers: E2B_03828775, E2B_03946636.

Organization: Health Canada

21 page(s)
January 2022

Req # A-2021-001164

Adverse Drug Reactions (ADRs) for ENOXAPARIN SODIUM. Report numbers: 928852, 000938779, 932507, 930509, 928081, 930339.

Organization: Health Canada

29 page(s)
January 2022

Req # A-2021-001168

Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: E2B_03608095, 000945402.

Organization: Health Canada

49 page(s)
January 2022

Req # A-2021-001208

Adverse Drug Reactions (ADRs) for Furosemide. Report numbers: 927098, 928248, 928788, 929346, 929634, 929885, 931911, 932278, 933246, 933525, 934682, 935299, 935588, 935603, 937126, 937469, E2B_02831379, 939340, 939359, 940065.

Organization: Health Canada

169 page(s)
January 2022

Req # A-2021-001225

Adverse Drug Reactions (ADRs) for FUROSEMIDE. Report numbers: E2B_03743360, 000946426, 000937126, E2B_03738509, 000929796, 000932278, E2B_03899283, E2B_03904331, E2B_03755570.

Organization: Health Canada

179 page(s)
January 2022

Req # A-2021-001246

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-115145-17, Health Canada’s Monitoring Report of Staffing Activities for 2018-2019 and 2019-2020.

Organization: Health Canada

10 page(s)
January 2022

Req # A-2021-001247

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-121772-392.

Organization: Health Canada

23 page(s)
January 2022

Req # A-2021-001248

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-115132-114.

Organization: Health Canada

21 page(s)
January 2022

Req # A-2021-001260

Adverse Drug Reaction (ADR) for AGALSIDASE BETA. Report number: E2B_03614299.

Organization: Health Canada

41 page(s)
January 2022

Req # A-2021-001263

Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_03702639.

Organization: Health Canada

55 page(s)
January 2022
Date modified: